Navigation Links
Help for Psoriasis

New research shows the drug efalizumab may reduce symptoms of psoriasis and improve patients’ quality of life.//

Researchers from Loyola University studied more than 550 patients who had psoriasis. Patients received weekly injections of efalizumab (Raptiva) or a placebo for three months. Researchers evaluated the extent of each patient’s condition and rated the degree of scaling and thickness. Patients also completed a questionnaire that measured their quality of life and severity of symptoms.

Results of the study show patients who received efalizumab experienced a significant improvement in their symptoms and quality of life. Patients were considered to have improved if they scored at least 75 percent on the Psoriasis Area and Severity Index. Twenty-seven percent of the patients treated with efalizumab scored at least 75 percent, while only 4 percent of patients in placebo group achieved this score. Patients who took efalizumab also reported a better quality of life than those in the placebo group.

Efalizumab is a biologic drug that blocks immune cells. Researchers say the drug modulates T-cells, which bolster the body’s immune response. Kenneth Gordon, M.D., from the Loyola Psoriasis Center, says, “Biologics are injected, instead of swallowed and block immune cells that produce the dry, flaky skin.”

Psoriasis is triggered by an immune system response that causes skin cells to grow too quickly. The skin cells do not mature normally, and the skin piles up, causing red, scaly lesions to form. About 5 million people in the United States are affected by psoriasis. There is currently no cure, but researchers say new treatments, including biologics, are helping to improve the condition for many patients.

'"/>




Page: 1

Related medicine news :

1. New and unique treatment for Psoriasis patients
2. Comparing Psoriasis Treatments
3. Psoriasis Increases Cancer Risk
4. Managing Patients With Psoriasis
5. Effective Treatment Option For Psoriasis
6. Smoking Aggravates Psoriasis
7. Remicade Emerges as a Treatment for Patients Suffering From Psoriasis Disorder
8. Short-Term Topical Corticosteroid May Offer Relief for Certain Type of Psoriasis
9. Psoriasis raises risk for heart attack
10. Psoriasis Associated With Increased Risk For Heart Attack
11. Remicade Therapy Effective in Treating Severe Psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/19/2017)... (PRWEB) , ... May 19, 2017 , ... ... Charlotte health community, Queens University of Charlotte recently began recruitment efforts for the ... curriculum arms students with the skills, knowledge and expertise to approach and address ...
(Date:5/19/2017)... ... 2017 , ... Springfield, Vermont-based law firm of Brady/Callahan has released a new ... Hire An Experienced Personal Injury Attorney, " the article offers insight for people who ... article says. if someone is injured due to another person's negligence, they ...
(Date:5/19/2017)... ... May 19, 2017 , ... The Arnold and Mabel ... , Victor Acosta, Ph.D. - University of New Mexico, Jeremy Baskin, Ph.D. - ... of Washington, Erik Grumstrup, Ph.D. - Montana Stata University, A. Fatih Sarioglu, Ph.D. ...
(Date:5/19/2017)... ... 2017 , ... ML Billing, 2016 Billing Company of the Year , ... large group practices, is pleased to announce their 30th anniversary. Not only has ML ... in all aspects of full-service medical billing. This has allowed ML Billing to excel ...
(Date:5/19/2017)... ... 18, 2017 , ... Somnoware, a leading provider of digital health technology, announces ... CPAP devices and supplies, such as machines, filters, tubing, and masks. Using this feature, ... registration for daily usage data is automated, and a DME order is created for ...
Breaking Medicine News(10 mins):
(Date:5/8/2017)... May 8, 2017 MACRA replaces the ... fee for service reimbursement. Black Book Research crowdsource-surveyed 8,845 ... 1.       The Market for MIPS Compliance Technology is ... physician practices with 3 or more clinicians seek to ... Q4. "Given the magnitude of the changes, the hunt ...
(Date:5/4/2017)... 4, 2017  Fortuna Fix Inc. (" Fortuna "), ... first to eliminate the need for embryonic and fetal stem ... neurodegenerative diseases. Fortuna announced today the ... Michael Fehlings , MD, PhD; Father Kevin FitzGerald , ... and Professor James Giordano , PhD. "We ...
(Date:5/4/2017)... 2017  A new tight-tolerance microextrusion medical tubing ... materials, is being launched by Natvar, a Tekni-Plex ... in recent years to service a wide variety ... More expensive materials such as glass and fluoropolymers ... to their ability to consistently hold tolerances. This ...
Breaking Medicine Technology: